These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1174022)

  • 1. Comparison of cardiovascular, hyperthermic, and toxic effects of para-methoxyamphetamine (PMA) and 3, 4-methylenedioxyamphetamine (MDA).
    Nichols DE; Ilhan M; Long JP
    Arch Int Pharmacodyn Ther; 1975 Mar; 214(1):133-40. PubMed ID: 1174022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of para-methoxyamphetamine (PMA) on the cardiovascular system of the dog.
    Cheng HC; Long JP; Nichols DE; Barfknecht CF
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):83-8. PubMed ID: 4455128
    [No Abstract]   [Full Text] [Related]  

  • 3. The protective effects of methysergide, 6-hydroxydopamine and other agents on the toxicity of amphetamine, phentermine, MDA, PMA, and STP in mice.
    Lopatka JE; Brewerton CN; Brooks DS; Cook DA; Paton DM
    Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):677-87. PubMed ID: 989173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology and toxicity of 3,4-methylenedioxyamphetamine, para-methoxyamphetamine and related dimethoxyamphetamines.
    Paton DM; Bell JI; Yee R; Cook DA
    Proc West Pharmacol Soc; 1975; 18():229-31. PubMed ID: 1178673
    [No Abstract]   [Full Text] [Related]  

  • 5. Interactions of catecholaminergic receptor blockers with lethal doses of amphetamine or substituted amphetamines in mice.
    Davis WM; Hatoum HT; Waters IW
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):27-36. PubMed ID: 687391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological evidence for the central serotonergic effects of monomethoxyamphetamines.
    Menon MK; Tseng LF; Loh HH
    J Pharmacol Exp Ther; 1976 May; 197(2):272-9. PubMed ID: 946817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of novel amphetamine analogs in anesthetized rats.
    Thompson E; Wood L
    Res Commun Chem Pathol Pharmacol; 1978 Sep; 21(3):447-56. PubMed ID: 705023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 3,4-methylenedioxymethamphetamine and related amphetamines on autonomic and behavioral thermoregulation.
    Jaehne EJ; Salem A; Irvine RJ
    Pharmacol Biochem Behav; 2005 Jul; 81(3):485-96. PubMed ID: 15904952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
    Freezer A; Salem A; Irvine RJ
    Brain Res; 2005 Apr; 1041(1):48-55. PubMed ID: 15804499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic investigation of compounds related to 3,4-methylenedioxyamphetamine (MDA).
    Davis WM; Borne RF
    Subst Alcohol Actions Misuse; 1984; 5(2):105-10. PubMed ID: 6147902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of anesthesia and phenoxybenzamine on responses of dogs to IV subtoxic doses of 3,4-methylenedioxyamphetamine (MDA).
    Waters IW; Catravas JD; Davis WM
    Arch Int Pharmacodyn Ther; 1986 Jun; 281(2):240-51. PubMed ID: 3753103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of co-administration of 3,4-methylenedioxymethamphetamine ("ecstasy") or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats.
    Stanley N; Salem A; Irvine RJ
    Neuroscience; 2007 Apr; 146(1):321-9. PubMed ID: 17306465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative actions of monomethoxyamphetamines on the release and uptake of biogenic amines in brain tissue.
    Tseng LF; Menon MK; Loh HH
    J Pharmacol Exp Ther; 1976 May; 197(2):263-71. PubMed ID: 1271280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Properties of PME.
    Bell JI; Yee R; Cook DA; Paton DM
    Can Med Assoc J; 1974 Sep; 111(5):388. PubMed ID: 4414360
    [No Abstract]   [Full Text] [Related]  

  • 15. The contribution of the metabolite p-hydroxyamphetamine to the central actions of p-methoxyamphetamine.
    Kaminskas LM; Irvine RJ; Callaghan PD; White JM; Kirkbride P
    Psychopharmacology (Berl); 2002 Mar; 160(2):155-60. PubMed ID: 11875633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevance to hazards of MDMA (Ecstasy) abuse.
    Davis WM; Hatoum HT; Waters IW
    Alcohol Drug Res; 1987; 7(3):123-34. PubMed ID: 2881551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of amphetamine, 3,4-methylenedioxyamphetamine, p-methoxyamphetamine and related amphetamines on uptake of metaraminol and efflux of noradrenaline in adrenergic nerves of rabbit atria.
    Paton DM
    J Pharm Pharmacol; 1975 May; 27(5):361-2. PubMed ID: 239139
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antiarrhythmic, cardiovascular and toxic effects of 4-[3'-diethylamino-2'-hydroxypropyl]-ajmaline (Tachmalcor) in comparison with ajmaline and propranolol].
    Terhaag B; Förster W; Mest HJ; Schrör K
    Pharmazie; 1976; 31(1):39-44. PubMed ID: 1257278
    [No Abstract]   [Full Text] [Related]  

  • 19. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
    Hewton R; Salem A; Irvine RJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an i.v. lethal dose of 3,4-methylenedioxyamphetamine (MDA) in the dog and antagonism by chlorpromazine.
    Davis WM; Catravas JD; Waters IW
    Gen Pharmacol; 1986; 17(2):179-83. PubMed ID: 3699443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.